Warning Letter Close-Outs – June 2015
This article was originally published in The Gray Sheet
Five FDA medical device close-out letters were released in June.
You may also be interested in...
The company announced that results from the pivotal SPYRAL HTN-ON MED trial of its Symplicity renal denervation system will not be available until the trial completes enrollment next year. The company previously expected to be able to present favorable interim results from the trial in November.
The recall is related to the software’s mixing parameters, which may cause false positives if test samples contaminate each other.
Immunogenicity data from Valneva’s COV-COMPARE study are encouraging, but the inactivated vaccine will need proper efficacy data to gain a toehold in a crowded market.